# AXT Inc: overview AXTI · Nasdaq · CIK 1051627 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/axti.md) · [Financials](/companies/axti/financials.md) · [Filings](/companies/axti/filings.md) · [Insiders](/companies/axti/insiders.md) Latest reported revenue: [$47.6m](/filings/0001437749-26-027677.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-027677). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [23.6](/filings/0001437749-25-034843.md) | [25.1 d](/filings/0001437749-26-008612.md) | [19.4](/filings/0001437749-26-017054.md) | [18.0](/filings/0001437749-26-027677.md) | [28.0](/filings/0001437749-25-034843.md) | [23.0 d](/filings/0001437749-26-008612.md) | [26.9](/filings/0001437749-26-017054.md) | [47.6](/filings/0001437749-26-027677.md) | | Gross margin | % | [24.0%](/filings/0001437749-25-034843.md) | [17.6% d](/filings/0001437749-26-008612.md) | [(6.4%)](/filings/0001437749-26-017054.md) | [8.0%](/filings/0001437749-26-027677.md) | [22.3%](/filings/0001437749-25-034843.md) | [20.9% d](/filings/0001437749-26-008612.md) | [29.6%](/filings/0001437749-26-017054.md) | [44.9%](/filings/0001437749-26-027677.md) | | Operating margin | % | [(14.4%)](/filings/0001437749-25-034843.md) | [(24.6%) d](/filings/0001437749-26-008612.md) | [(53.1%)](/filings/0001437749-26-017054.md) | [(37.5%)](/filings/0001437749-26-027677.md) | [(4.0%)](/filings/0001437749-25-034843.md) | [(16.6%) d](/filings/0001437749-26-008612.md) | [(5.9%)](/filings/0001437749-26-017054.md) | [21.9%](/filings/0001437749-26-027677.md) | | Net margin | % | [(12.4%)](/filings/0001437749-25-034843.md) | [(20.3%) d](/filings/0001437749-26-008612.md) | [(45.5%)](/filings/0001437749-26-017054.md) | [(39.0%)](/filings/0001437749-26-027677.md) | [(6.8%)](/filings/0001437749-25-034843.md) | [(15.4%) d](/filings/0001437749-26-008612.md) | [(6.0%)](/filings/0001437749-26-017054.md) | [23.4%](/filings/0001437749-26-027677.md) | | Diluted EPS | $ per share | [(0.07)](/filings/0001437749-25-034843.md) | not reported | [(0.20)](/filings/0001437749-26-017054.md) | [(0.16)](/filings/0001437749-26-027677.md) | [(0.04)](/filings/0001437749-25-034843.md) | not reported | [(0.03)](/filings/0001437749-26-017054.md) | [0.17](/filings/0001437749-26-027677.md) | | Free cash flow | $m | [(6.4) d](/filings/0001437749-25-034843.md) | [1.1 d](/filings/0001437749-26-008612.md) | [(3.9)](/filings/0001437749-26-017054.md) | [(4.9) d](/filings/0001437749-26-027677.md) | [(11.3) d](/filings/0001437749-25-034843.md) | [1.3 d](/filings/0001437749-26-008612.md) | [(13.1)](/filings/0001437749-26-017054.md) | [3.6 d](/filings/0001437749-26-027677.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [137](/filings/0001558370-24-003410.md) | [141](/filings/0001558370-24-003410.md) | [75.8](/filings/0001437749-26-008612.md) | [99.4](/filings/0001437749-26-008612.md) | [88.3](/filings/0001437749-26-008612.md) | | Gross margin | % | [34.5%](/filings/0001558370-24-003410.md) | [36.9%](/filings/0001558370-25-003004.md) | [17.6%](/filings/0001437749-26-008612.md) | [24.0%](/filings/0001437749-26-008612.md) | [12.7%](/filings/0001437749-26-008612.md) | | Operating margin | % | [9.4%](/filings/0001558370-24-003410.md) | [8.9%](/filings/0001558370-25-003004.md) | [(28.5%)](/filings/0001437749-26-008612.md) | [(14.9%)](/filings/0001437749-26-008612.md) | [(24.9%)](/filings/0001437749-26-008612.md) | | Net margin | % | [10.6%](/filings/0001558370-24-003410.md) | [11.2%](/filings/0001558370-25-003004.md) | [(23.6%)](/filings/0001437749-26-008612.md) | [(11.7%)](/filings/0001437749-26-008612.md) | [(24.1%)](/filings/0001437749-26-008612.md) | | Diluted EPS | $ per share | [0.34](/filings/0001558370-24-003410.md) | [0.37](/filings/0001558370-25-003004.md) | [(0.42)](/filings/0001437749-26-008612.md) | [(0.27)](/filings/0001437749-26-008612.md) | [(0.49)](/filings/0001437749-26-008612.md) | | Free cash flow | $m | [(33.0)](/filings/0001558370-24-003410.md) | [(37.2)](/filings/0001558370-25-003004.md) | [(7.1)](/filings/0001437749-26-008612.md) | [(17.9)](/filings/0001437749-26-008612.md) | [(18.8)](/filings/0001437749-26-008612.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/axti/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $365.6m | 5,072,242 | | Added +3,952,774 | | [Marex Group Ltd](/funds/1997464.md) | 2026-06-30 | $256.9m | 3,563,896 | | Added +3,555,887 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $254.2m | 3,527,115 | | Added +1,100,883 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $196.3m | 2,722,914 | | Added +444,511 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $182.7m | 2,534,400 | Put | Added +1,192,800 | | [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $162.2m | 2,250,085 | | Added +1,473,829 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $161.2m | 2,236,400 | Call | Added +258,600 | | [Marex Group Ltd](/funds/1997464.md) | 2026-06-30 | $144.2m | 2,000,000 | Put | New +2,000,000 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $126.7m | 1,758,421 | | New +1,758,421 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $125.2m | 1,736,210 | | Added +1,148,531 | ## Recent filings [All 719 filings](/companies/axti/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-29 | 16:16 ET | [8-K](/filings/0001437749-26-033941.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-033941 | | 2026-10-28 | 06:10 ET | [8-K](/filings/0001213900-26-113058.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-113058 | | 2026-08-13 | 16:16 ET | [10-Q](/filings/0001437749-26-027677.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027677 | | 2026-07-30 | 16:15 ET | [8-K](/filings/0001437749-26-025061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-025061 | | 2026-07-29 | 16:17 ET | [8-K](/filings/0001437749-26-024883.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-024883 | | 2026-07-29 | 16:17 ET | [8-K](/filings/0001437749-26-024882.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-26-024882 | | 2026-07-22 | 17:05 ET | [8-K](/filings/0001437749-26-024184.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-024184 | | 2026-07-08 | 09:29 ET | [8-K](/filings/0001437749-26-022984.md) | 2.04 Item not in the standard list | 0001437749-26-022984 | | 2026-07-02 | 17:02 ET | [8-K](/filings/0001437749-26-022557.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-022557 | | 2026-06-22 | 16:08 ET | [8-K](/filings/0001437749-26-021307.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-021307 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-008612.md), filed Mar 17, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/ac55b109-e3a4-41c3-93f3-cc452f2a6fa1) ## About the filer - CIK: 1051627 - Tickers: AXTI - Exchange: Nasdaq - SIC code: 3674 Semiconductors & Related Devices - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 20:06 ET. No prices; not investment advice.